Vol. 5 No. 4S (2011)

Case report

• Imatinib dose optimisation following the disease progression in a patient with metastatic GIST

  Mariangela Parodi, Monica Boitano, Luciano Canobbio

  3-6

  • PDF

• Imatinib as adjuvant therapy for high risk GIST: a case report

  Patrizia Lista, Agostino Ponzetti

  7-12

  • PDF

• Appropriate durations of adjuvant imatinib in patients with high-risk gastrointestinal stromal tumor (GIST) the better choice, for the year 2010

  Lucia Tozzi

  13-16

  • PDF